HIV mper bnabs for prevention, therapy, or cure
Ended Awarded Last action
- Contract number
- HHSN26100001
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,074,783
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $5,074,782.64 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$16,411 | |
| Other Administrative Action | $21,727 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $5,069,466 |
About this award
This is a federal contract award from the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The $5,074,782.64 contract is for HIV MPER BNABS (monoclonal antibodies) for prevention, therapy, or cure. It is a delivery order contract with a cost-no-fee pricing type. The contract has an ultimate completion date of May 24, 2023 and was awarded on September 26, 2015. There is no set-aside designation mentioned for this contract. Leidos Biomedical Research Inc. is an NCI Federally Funded Research and Development Center (FFRDC) contractor that provides a range of biomedical research and facilities support services to federal agencies, with a focus on supporting programs at the National Institutes of Health (NIH). This contract award further supports Leidos Biomedical Research Inc.'s role in advancing research for HIV/AIDS, a key area of focus for the NCI and NIH.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 26, 2015.
How much is contract HHSN26100001 worth?
The government has obligated $5,074,783 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award